SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052064
Filing Date
2020-11-09
Accepted
2020-11-06 18:12:43
Documents
94
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne-10q_20200930.htm   iXBRL 10-Q 3016690
2 EX-10.1 srne-ex101_61.htm EX-10.1 269122
3 EX-10.2 srne-ex102_62.htm EX-10.2 231594
4 EX-10.3 srne-ex103_63.htm EX-10.3 304314
5 EX-10.7 srne-ex107_225.htm EX-10.7 121092
6 EX-31.1 srne-ex311_6.htm EX-31.1 17156
7 EX-31.2 srne-ex312_9.htm EX-31.2 17008
8 EX-32.1 srne-ex321_8.htm EX-32.1 14947
  Complete submission text file 0001564590-20-052064.txt   12488724

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA srne-20200930.xsd EX-101.SCH 78640
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20200930_cal.xml EX-101.CAL 74942
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20200930_def.xml EX-101.DEF 331281
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20200930_lab.xml EX-101.LAB 561150
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20200930_pre.xml EX-101.PRE 491519
14 EXTRACTED XBRL INSTANCE DOCUMENT srne-10q_20200930_htm.xml XML 2219617
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 201295539
SIC: 2836 Biological Products, (No Diagnostic Substances)